[1] |
FANG Yanhui , MA Caijuan , ZHANG Chunli , ZHAI Jiawei , ZHU Qiaoying , LIU Yin , ZHAO Xiwa .
miR-496 inhibits proliferation, migration and invasion of HeLa cell in cervical cancer via SFMBT1
[J]. China Oncology, 2021, 31(8): 697-703.
|
[2] |
LONG Xingtao , ZHOU Qi , WANG Dong , CHEN Yuemei , JIN Fujun .
The prognostic value of revised 2018 FIGO stage ⅢC in cervical cancer
[J]. China Oncology, 2021, 31(8): 725-733.
|
[3] |
WEI Yu , ZHANG Tingwei , HE Yi , LI Jun , BI Jianbin , ZENG Yu , WAN Lijun , WU Gaoliang , WANG Huansheng , ZHANG Jun , ZHU Wei , QU Yuanyuan , ZHU Yao , YE Dingwei .
Preliminary study on efficacy and safety of fluzoparib in patients with metastatic castration-resistant prostate cancer
[J]. China Oncology, 2021, 31(7): 561-566.
|
[4] |
DONG Shijie, HU Xiaoxin, WANG Wei, YANG Meng, YUE Lei, TONG Tong, GU Yajia.
Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model
[J]. China Oncology, 2021, 31(6): 460-467.
|
[5] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[6] |
YI Weili , ZHAO Wencheng , HUANG Dongning , QIN Li , WU Xintian , ZHOU Fei , WU Fengying .
Analysis of immune-related adverse events and its correlation with efficacy of anti-PD-1 monotherapy in advanced non-small cell lung cancer
[J]. China Oncology, 2021, 31(3): 203-211.
|
[7] |
YANG Yiqi , WU Hao , YIN Yongmei .
Current status and controversy of cardio-oncology in breast cancer
[J]. China Oncology, 2020, 30(6): 475-480.
|
[8] |
FENG Zheng, WU Xiaohua.
Hematological toxicities of maintenance PARP inhibitors for patients with platinum-sensitive recurrent ovarian cancer
[J]. China Oncology, 2020, 30(4): 299-304.
|
[9] |
SHEN Jie , MO Miao , YUAN Jing , ZHOU Changming , WANG Zezhou , ZHANG Zhihong , WEN Hao , WU Xiaohua , ZHENG Ying .
Long-term survival report on 1 313 patients with locally advanced cervical cancer: a hospital-based real world study
[J]. China Oncology, 2020, 30(3): 192-198.
|
[10] |
CHEN Xiaohui, WANG Jiazhou, HU Weigang, PENG Jiayuan, ZHAI Peng.
Dosimetric impact of machine and treatment planning system on knowledge-based planning: a study based on cervical cancer IMRT plan
[J]. China Oncology, 2020, 30(10): 821-825.
|
[11] |
KANG Xun,ZHANG Xiyou,CHEN Feng,LI Dandan,DONG Qianqian,SONG Qingkun,ZHONG Xiaosong,LI Wenbin .
The toxicity of chimeric antigen receptor T-cell immunotherapy in B-cell lymphoma: a Meta-analysis
[J]. China Oncology, 2019, 29(8): 568-575.
|
[12] |
WANG Li,REN Yulan,WANG Huaying .
Pulmonary embolism after radical surgery of cervical cancer: a case report and the review of literature
[J]. China Oncology, 2019, 29(8): 599-601.
|
[13] |
SUN Jianda, XIONG Jun, ZHANG Hanxiong, CHEN Yibiao.
Prognostic values of hematological biomarkers in locoregionally advanced nasopharyngeal carcinoma
[J]. China Oncology, 2019, 29(7): 528-534.
|
[14] |
LIU Shan, FANG Juan, WANG Lili, ZHANG Yinghong, DU Wenjie, ZHU Taohua.
Association between peripheral nerve invasion and recurrence risk factors in cervical cancer
[J]. China Oncology, 2019, 29(6): 439-444.
|
[15] |
ZHAO Yudi, TAN Fang, YAN Zhiling, LI Yingfu, DAI Shuying, ZHOU Ziyun, ZHANG Xinwen, LIU Shuyuan, SHI Li, YAO Yufeng.
Correlation between genetic variants in CD44 gene and cervical cancer and non-small cell lung cancer
[J]. China Oncology, 2019, 29(4): 277-283.
|